AMYS TREAT INC (EIN 262350766) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2007

Legal Domicile

Principal Officer

CANDACE FENNESSY

Tax Period

2023-01-01 to 2023-12-31

AMYS TREAT INC, founded in 2007, is a small nonprofit in the Diseases & Disorders sector that reported $214K in total revenue in fiscal year 2023. Revenue surged 140% from the prior year, signaling strong growth momentum. Expenses of $182K left a modest 15% surplus.

Mission

PROVIDE SUPPORT AND SERVICES TO THOSE LIVING WITH CANCER.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $67,976

Program Service Revenue $146,006

Investment Income $63

Other Revenue $0

TOTAL REVENUE $214,045

Expense Breakdown

Grants Paid $165,947

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $165,947

Other Expenses $16,176

TOTAL EXPENSES $182,123

Year-over-Year Comparison

	2023	2022	Change
Revenue	$214,045	$89,109	+1.4%
Expenses	$182,123	$152,681	+0.2%
Net Income	$31,922	$-63,572	-1.5%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
RACHEL ONEILL	BOARD MEMBER	6.00	Director	$0	$0	$0
LENORE ROGERS	BOARD MEMBER	2.00	Director	$0	$0	$0
LAURA KELLEY	BOARD MEMBER	1.00	Director	$0	$0	$0
BARBARA CIVIELLO	BOARD MEMBER	1.00	Director	$0	$0	$0
ROBIN LUCZEK	BOARD MEMBER	1.00	Director	$0	$0	$0
NICK PELLMAN	SECRETARY	1.00	Officer Director	$0	$0	$0
MICHAEL MESERVE	TREASURER	6.00	Officer Director	$0	$0	$0
CANDACE FENNESSY	BOARD PRESIDENT	10.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	No data	No data	No data	No data
2023	$214,045	$182,123	$125,087	$31,922
2022	$89,109	$152,681	$93,165	$-63,572
2021	$149,874	$112,959	$157,138	$36,915
2020	$149,631	$98,222	$176,899	$51,409
2019	$161,021	$124,123	$126,082	$36,898
2018	$92,550	$104,757	$88,917	$-12,207

AMYS TREAT INC